Browsing by Author Ganotakis, E. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 12 of 12
TitleAuthor(s)Issue date
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT studyAthyros, V. G.; Karagiannis, A.; Ganotakis, E. S.; Paletas, K.; Nicolaou, V.; Bacharoudis, G.; Tziomalos, K.; Alexandrides, T.; Liberopoulos, E. N.; Mikhailidis, D. P.24-Nov-2015
Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohortAthyros, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Papageorgiou, A. A.; Ganotakis, E. S.; Tziomalos, K.; Kakafika, A. I.; Karagiannis, A.; Lambropoulos, S.; Elisaf, M. S.24-Nov-2015
Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek studyAthyros, V. G.; Ganotakis, E. S.; Bathianaki, M.; Monedas, I.; Goudevenos, I. A.; Papageorgiou, A. A.; Papathanasiou, A.; Kakafika, A. I.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) StudyDiamantopoulos, E. J.; Athyros, V. G.; Yfanti, G. K.; Migdalis, E. N.; Elisaf, M. S.; Vardas, P. E.; Manolis, A. S.; Karamitsos, D. T.; Ganotakis, E. S.; Hatseras, D.24-Nov-2015
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrateChristidis, D. S.; Liberopoulos, E. N.; Kakafika, A. I.; Miltiadous, G. A.; Cariolou, M.; Ganotakis, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) StudyAthyros, V. G.; Mikhailidis, D. P.; Liberopoulos, E. N.; Kakafika, A. I.; Karagiannis, A.; Papageorgiou, A. A.; Tziomalos, K.; Ganotakis, E. S.; Elisaf, M. S.24-Nov-2015
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levelsAthyros, V. G.; Mikhailidis, D. P.; Kakafika, A. I.; Karagiannis, A.; Hatzitolios, A.; Tziomalos, K.; Ganotakis, E. S.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre StudyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Ganotakis, E. S.; Symeonidis, A. N.; Daskalopoulou, S. S.; Kakafika, A. I.; Elisaf, M. S.24-Nov-2015
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsAthyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015
Prevalence of vascular disease in metabolic syndrome using three proposed definitionsAthyros, V. G.; Ganotakis, E. S.; Elisaf, M. S.; Liberopoulos, E. N.; Goudevenos, I. A.; Karagiannis, A.24-Nov-2015
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT studyAthyros, V. G.; Giouleme, O.; Ganotakis, E. S.; Elisaf, M. S.; Tziomalos, K.; Vassiliadis, T.; Liberopoulos, E. N.; Theocharidou, E.; Karagiannis, A.; Mikhailidis, D. P.24-Nov-2015
Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)Milionis, H. J.; Rizos, E.; Kostapanos, M.; Filippatos, T. D.; Gazi, I. F.; Ganotakis, E. S.; Goudevenos, J.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015